25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AAVXF (Abivax) Stock Analysis
Buy, Hold or Sell?

Let's analyze Abivax together

I guess you are interested in ABIVAX Société Anonyme. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Abivax’s Financial Insights
  • 📈 Technical Analysis (TA) – Abivax’s Price Targets

I'm going to help you getting a better view of ABIVAX Société Anonyme. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about ABIVAX Société Anonyme

I send you an email if I find something interesting about ABIVAX Société Anonyme.

1. Quick Overview

1.1. Quick analysis of Abivax (30 sec.)










1.2. What can you expect buying and holding a share of Abivax? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.70
Expected worth in 1 year
$-10.04
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-10.74
Return On Investment
-184.9%

For what price can you sell your share?

Current Price per Share
$5.81
Expected price per share
$0 - $5.89
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Abivax (5 min.)




Live pricePrice per Share (EOD)
$5.81
Intrinsic Value Per Share
$-36.51 - $-18.88
Total Value Per Share
$-35.81 - $-18.18

2.2. Growth of Abivax (5 min.)




Is Abivax growing?

Current yearPrevious yearGrowGrow %
How rich?$44.4m$214.8m-$170.3m-383.0%

How much money is Abivax making?

Current yearPrevious yearGrowGrow %
Making money-$176.2m-$147.7m-$28.5m-16.2%
Net Profit Margin0.0%-3,197.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Abivax (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Abivax?

Welcome investor! Abivax's management wants to use your money to grow the business. In return you get a share of Abivax.

First you should know what it really means to hold a share of Abivax. And how you can make/lose money.

Speculation

The Price per Share of Abivax is $5.81. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Abivax.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Abivax, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.70. Based on the TTM, the Book Value Change Per Share is $-2.69 per quarter. Based on the YOY, the Book Value Change Per Share is $3.35 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Abivax.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.78-47.8%-2.78-47.8%-2.33-40.1%-1.46-25.2%-0.87-15.0%
Usd Book Value Change Per Share-2.69-46.2%-2.69-46.2%3.3557.7%0.081.3%0.010.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-2.69-46.2%-2.69-46.2%3.3557.7%0.081.3%0.010.2%
Usd Price Per Share7.37-7.37-10.19-19.27-13.11-
Price to Earnings Ratio-2.65--2.65--4.37--26.28--23.86-
Price-to-Total Gains Ratio-2.74--2.74-3.04--21.16--37.46-
Price to Book Ratio10.51-10.51-3.01-152.71-85.29-
Price-to-Total Gains Ratio-2.74--2.74-3.04--21.16--37.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.81
Number of shares172
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-2.690.08
Usd Total Gains Per Share-2.690.08
Gains per Quarter (172 shares)-462.0013.07
Gains per Year (172 shares)-1,848.0152.30
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1848-185805242
20-3696-3706010594
30-5544-55540157146
40-7392-74020209198
50-9240-92500261250
60-11088-110980314302
70-12936-129460366354
80-14784-147940418406
90-16632-166420471458
100-18480-184900523510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.012.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%4.08.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.012.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%4.08.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of ABIVAX Société Anonyme compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.686-2.6860%3.355-180%0.076-3634%0.011-23476%
Book Value Per Share--0.7010.7010%3.387-79%0.940-25%0.867-19%
Current Ratio--1.8381.8380%4.083-55%2.295-20%3.785-51%
Debt To Asset Ratio--0.8020.8020%0.401+100%0.770+4%0.508+58%
Debt To Equity Ratio--4.0574.0570%0.669+507%11.959-66%6.238-35%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--445012211.000445012211.0000%788650793.000-44%1223565401.800-64%1186929986.571-63%
Eps---2.779-2.7790%-2.330-16%-1.462-47%-0.870-69%
Ev To Ebitda Ratio--infinfnan%-5.920nan%infnan%infnan%
Ev To Sales Ratio--infinfnan%170.667+inf%infnan%infnan%
Free Cash Flow Per Share---2.674-2.6740%-1.683-37%-1.381-48%-0.838-69%
Free Cash Flow To Equity Per Share---2.186-2.1860%4.111-153%0.442-595%0.228-1058%
Gross Profit Margin--1.0001.0000%1.044-4%0.855+17%0.928+8%
Intrinsic Value_10Y_max---18.881--------
Intrinsic Value_10Y_min---36.510--------
Intrinsic Value_1Y_max---1.068--------
Intrinsic Value_1Y_min---2.332--------
Intrinsic Value_3Y_max---3.837--------
Intrinsic Value_3Y_min---8.197--------
Intrinsic Value_5Y_max---7.363--------
Intrinsic Value_5Y_min---15.322--------
Market Cap368462647.000-27%467395819.000467395819.0000%646236553.000-28%1222078349.000-62%831419157.000-44%
Net Profit Margin----0%-31.9710%-769.4370%-767.2970%
Operating Margin----0%-28.9790%-802.7250%-850.1890%
Operating Ratio----0%27.592-100%855.725-100%878.625-100%
Pb Ratio8.284-27%10.50810.5080%3.008+249%152.714-93%85.290-88%
Pe Ratio-2.091+21%-2.652-2.6520%-4.374+65%-26.277+891%-23.860+800%
Price Per Share5.810-27%7.3707.3700%10.190-28%19.270-62%13.110-44%
Price To Free Cash Flow Ratio-2.173+21%-2.756-2.7560%-6.054+120%-26.000+843%-24.116+775%
Price To Total Gains Ratio-2.163+21%-2.744-2.7440%3.037-190%-21.156+671%-37.463+1265%
Quick Ratio--1.7221.7220%4.128-58%2.154-20%4.804-64%
Return On Assets---0.784-0.7840%-0.412-47%-0.577-26%-0.429-45%
Return On Equity---3.962-3.9620%-0.688-83%-9.431+138%-4.972+25%
Total Gains Per Share---2.686-2.6860%3.355-180%0.076-3634%0.011-23476%
Usd Book Value--44480064.00044480064.0000%214826960.000-79%59605521.600-25%55001116.000-19%
Usd Book Value Change Per Share---2.686-2.6860%3.355-180%0.076-3634%0.011-23476%
Usd Book Value Per Share--0.7010.7010%3.387-79%0.940-25%0.867-19%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--445012211.000445012211.0000%788650793.000-44%1223565401.800-64%1186929986.571-63%
Usd Eps---2.779-2.7790%-2.330-16%-1.462-47%-0.870-69%
Usd Free Cash Flow---169567640.000-169567640.0000%-106744920.000-37%-87609198.181-48%-53171672.690-69%
Usd Free Cash Flow Per Share---2.674-2.6740%-1.683-37%-1.381-48%-0.838-69%
Usd Free Cash Flow To Equity Per Share---2.186-2.1860%4.111-153%0.442-595%0.228-1058%
Usd Market Cap368462647.000-27%467395819.000467395819.0000%646236553.000-28%1222078349.000-62%831419157.000-44%
Usd Price Per Share5.810-27%7.3707.3700%10.190-28%19.270-62%13.110-44%
Usd Profit---176242000.000-176242000.0000%-147740000.000-16%-94547200.000-46%-56067800.000-68%
Usd Revenue----0%4621000.000-100%1851000.000-100%947500.000-100%
Usd Total Gains Per Share---2.686-2.6860%3.355-180%0.076-3634%0.011-23476%
 EOD+3 -5MRQTTM+0 -0YOY+3 -325Y+7 -2710Y+7 -27

3.3 Fundamental Score

Let's check the fundamental score of ABIVAX Société Anonyme based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.091
Price to Book Ratio (EOD)Between0-18.284
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.722
Current Ratio (MRQ)Greater than11.838
Debt to Asset Ratio (MRQ)Less than10.802
Debt to Equity Ratio (MRQ)Less than14.057
Return on Equity (MRQ)Greater than0.15-3.962
Return on Assets (MRQ)Greater than0.05-0.784
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of ABIVAX Société Anonyme based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5014.708
Ma 20Greater thanMa 506.855
Ma 50Greater thanMa 1006.339
Ma 100Greater thanMa 2007.885
OpenGreater thanClose5.810
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About ABIVAX Société Anonyme

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

Fundamental data was last updated by Penke on 2025-04-04 00:21:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Abivax earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Abivax to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ABIVAX Société Anonyme:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-3,197.1%+3,197.1%
TTM-5Y-76,943.7%+76,943.7%
5Y-76,943.7%10Y-76,729.7%-214.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--109.6%+109.6%
TTM--185.9%+185.9%
YOY-3,197.1%-206.2%-2,990.9%
5Y-76,943.7%-399.1%-76,544.6%
10Y-76,729.7%-522.9%-76,206.8%
4.3.1.2. Return on Assets

Shows how efficient Abivax is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Abivax to the Biotechnology industry mean.
  • -78.4% Return on Assets means that Abivax generated $-0.78 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ABIVAX Société Anonyme:

  • The MRQ is -78.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -78.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-78.4%TTM-78.4%0.0%
TTM-78.4%YOY-41.2%-37.1%
TTM-78.4%5Y-57.7%-20.6%
5Y-57.7%10Y-42.9%-14.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-78.4%-14.2%-64.2%
TTM-78.4%-14.6%-63.8%
YOY-41.2%-14.4%-26.8%
5Y-57.7%-15.5%-42.2%
10Y-42.9%-18.0%-24.9%
4.3.1.3. Return on Equity

Shows how efficient Abivax is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Abivax to the Biotechnology industry mean.
  • -396.2% Return on Equity means Abivax generated $-3.96 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ABIVAX Société Anonyme:

  • The MRQ is -396.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -396.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-396.2%TTM-396.2%0.0%
TTM-396.2%YOY-68.8%-327.5%
TTM-396.2%5Y-943.1%+546.9%
5Y-943.1%10Y-497.2%-445.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-396.2%-17.5%-378.7%
TTM-396.2%-17.9%-378.3%
YOY-68.8%-19.1%-49.7%
5Y-943.1%-24.3%-918.8%
10Y-497.2%-26.0%-471.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of ABIVAX Société Anonyme.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Abivax is operating .

  • Measures how much profit Abivax makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Abivax to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ABIVAX Société Anonyme:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-2,897.9%+2,897.9%
TTM-5Y-80,272.5%+80,272.5%
5Y-80,272.5%10Y-85,018.9%+4,746.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.7%+223.7%
TTM--281.1%+281.1%
YOY-2,897.9%-226.6%-2,671.3%
5Y-80,272.5%-393.2%-79,879.3%
10Y-85,018.9%-503.6%-84,515.3%
4.3.2.2. Operating Ratio

Measures how efficient Abivax is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of ABIVAX Société Anonyme:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY27.592-27.592
TTM-5Y855.725-855.725
5Y855.72510Y878.625-22.900
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.324-2.324
TTM-3.192-3.192
YOY27.5923.069+24.523
5Y855.7255.100+850.625
10Y878.6256.912+871.713
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of ABIVAX Société Anonyme.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Abivax is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.84 means the company has $1.84 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of ABIVAX Société Anonyme:

  • The MRQ is 1.838. The company is able to pay all its short-term debts. +1
  • The TTM is 1.838. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.838TTM1.8380.000
TTM1.838YOY4.083-2.244
TTM1.8385Y2.295-0.457
5Y2.29510Y3.785-1.489
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8383.776-1.938
TTM1.8383.930-2.092
YOY4.0834.470-0.387
5Y2.2955.748-3.453
10Y3.7856.099-2.314
4.4.3.2. Quick Ratio

Measures if Abivax is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Abivax to the Biotechnology industry mean.
  • A Quick Ratio of 1.72 means the company can pay off $1.72 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ABIVAX Société Anonyme:

  • The MRQ is 1.722. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.722. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.722TTM1.7220.000
TTM1.722YOY4.128-2.406
TTM1.7225Y2.154-0.432
5Y2.15410Y4.804-2.651
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7223.102-1.380
TTM1.7223.367-1.645
YOY4.1284.358-0.230
5Y2.1545.731-3.577
10Y4.8046.427-1.623
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of ABIVAX Société Anonyme.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Abivax assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Abivax to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.80 means that Abivax assets are financed with 80.2% credit (debt) and the remaining percentage (100% - 80.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ABIVAX Société Anonyme:

  • The MRQ is 0.802. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.802. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.802TTM0.8020.000
TTM0.802YOY0.401+0.402
TTM0.8025Y0.770+0.032
5Y0.77010Y0.508+0.262
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8020.340+0.462
TTM0.8020.340+0.462
YOY0.4010.318+0.083
5Y0.7700.364+0.406
10Y0.5080.393+0.115
4.5.4.2. Debt to Equity Ratio

Measures if Abivax is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Abivax to the Biotechnology industry mean.
  • A Debt to Equity ratio of 405.7% means that company has $4.06 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ABIVAX Société Anonyme:

  • The MRQ is 4.057. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.057. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.057TTM4.0570.000
TTM4.057YOY0.669+3.388
TTM4.0575Y11.959-7.902
5Y11.95910Y6.238+5.720
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0570.400+3.657
TTM4.0570.407+3.650
YOY0.6690.389+0.280
5Y11.9590.428+11.531
10Y6.2380.460+5.778
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Abivax generates.

  • Above 15 is considered overpriced but always compare Abivax to the Biotechnology industry mean.
  • A PE ratio of -2.65 means the investor is paying $-2.65 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ABIVAX Société Anonyme:

  • The EOD is -2.091. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.652. Based on the earnings, the company is expensive. -2
  • The TTM is -2.652. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.091MRQ-2.652+0.561
MRQ-2.652TTM-2.6520.000
TTM-2.652YOY-4.374+1.722
TTM-2.6525Y-26.277+23.625
5Y-26.27710Y-23.860-2.417
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.091-1.613-0.478
MRQ-2.652-2.674+0.022
TTM-2.652-3.228+0.576
YOY-4.374-3.337-1.037
5Y-26.277-6.386-19.891
10Y-23.860-7.262-16.598
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ABIVAX Société Anonyme:

  • The EOD is -2.173. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.756. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.756. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.173MRQ-2.756+0.583
MRQ-2.756TTM-2.7560.000
TTM-2.756YOY-6.054+3.298
TTM-2.7565Y-26.000+23.244
5Y-26.00010Y-24.116-1.884
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.173-2.172-0.001
MRQ-2.756-3.714+0.958
TTM-2.756-4.332+1.576
YOY-6.054-4.479-1.575
5Y-26.000-8.682-17.318
10Y-24.116-9.845-14.271
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Abivax is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 10.51 means the investor is paying $10.51 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of ABIVAX Société Anonyme:

  • The EOD is 8.284. Based on the equity, the company is overpriced. -1
  • The MRQ is 10.508. Based on the equity, the company is expensive. -2
  • The TTM is 10.508. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD8.284MRQ10.508-2.224
MRQ10.508TTM10.5080.000
TTM10.508YOY3.008+7.500
TTM10.5085Y152.714-142.206
5Y152.71410Y85.290+67.425
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.2841.537+6.747
MRQ10.5082.269+8.239
TTM10.5082.443+8.065
YOY3.0082.468+0.540
5Y152.7143.790+148.924
10Y85.2904.287+81.003
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets205,228
Total Liabilities164,644
Total Stockholder Equity40,584
 As reported
Total Liabilities 164,644
Total Stockholder Equity+ 40,584
Total Assets = 205,228

Assets

Total Assets205,228
Total Current Assets170,671
Long-term Assets34,558
Total Current Assets
Cash And Cash Equivalents 144,221
Net Receivables 15,663
Other Current Assets 10,787
Total Current Assets  (as reported)170,671
Total Current Assets  (calculated)170,671
+/-0
Long-term Assets
Property Plant Equipment 2,665
Goodwill 18,419
Long Term Investments 126
Intangible Assets 6,606
Long-term Assets Other 6,742
Long-term Assets  (as reported)34,558
Long-term Assets  (calculated)34,558
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities92,834
Long-term Liabilities71,810
Total Stockholder Equity40,584
Total Current Liabilities
Short-term Debt 43,769
Short Long Term Debt 42,837
Accounts payable 43,824
Other Current Liabilities 532
Total Current Liabilities  (as reported)92,834
Total Current Liabilities  (calculated)130,962
+/- 38,128
Long-term Liabilities
Long term Debt 52,161
Capital Lease Obligations 2,363
Long-term Liabilities Other 13,023
Long-term Liabilities  (as reported)71,810
Long-term Liabilities  (calculated)67,547
+/- 4,263
Total Stockholder Equity
Common Stock633
Retained Earnings -438,879
Accumulated Other Comprehensive Income -75
Other Stockholders Equity 478,905
Total Stockholder Equity (as reported)40,584
Total Stockholder Equity (calculated)40,584
+/-0
Other
Capital Stock633
Cash and Short Term Investments 144,221
Common Stock Shares Outstanding 63,348
Liabilities and Stockholders Equity 205,228
Net Debt -46,860
Net Invested Capital 135,582
Net Working Capital 77,837
Property Plant and Equipment Gross 4,029
Short Long Term Debt Total 97,361



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
38,463
37,966
76,268
60,597
53,815
54,048
51,728
71,298
110,365
73,352
327,062
205,228
205,228327,06273,352110,36571,29851,72854,04853,81560,59776,26837,96638,463
   > Total Current Assets 
5,600
5,640
43,154
27,841
20,876
20,977
18,244
36,544
74,713
48,191
285,972
170,671
170,671285,97248,19174,71336,54418,24420,97720,87627,84143,1545,6405,600
       Cash And Cash Equivalents 
2,908
1,221
25,126
7,937
1,881
7,996
9,765
29,296
60,695
26,944
251,942
144,221
144,221251,94226,94460,69529,2969,7657,9961,8817,93725,1261,2212,908
       Short-term Investments 
400
1,703
14,001
15,050
15,151
5,006
6
6
6
6
9,050
0
09,05066665,00615,15115,05014,0011,703400
       Net Receivables 
0
2,389
3,909
4,803
3,647
7,775
6,979
6,918
8,339
8,821
19,099
15,663
15,66319,0998,8218,3396,9186,9797,7753,6474,8033,9092,3890
       Other Current Assets 
0
0
1
-1
-1
-1
342
324
1,673
9,231
6,018
10,787
10,7876,0189,2311,673324342-1-1-1100
   > Long-term Assets 
32,863
32,326
33,113
32,757
32,939
33,071
33,483
34,754
35,652
25,161
41,090
34,558
34,55841,09025,16135,65234,75433,48333,07132,93932,75733,11332,32632,863
       Property Plant Equipment 
66
231
167
192
201
151
134
100
93
322
878
2,665
2,6658783229310013415120119216723166
       Goodwill 
32,754
32,005
32,005
32,005
32,005
32,005
32,005
32,005
32,005
22,337
18,419
18,419
18,41918,41922,33732,00532,00532,00532,00532,00532,00532,00532,00532,754
       Long Term Investments 
0
0
0
0
731
0
0
221
0
0
124
126
12612400221007310000
       Intangible Assets 
0
4
2
0
0
0
32,090
32,102
32,098
23,524
6,604
6,606
6,6066,60423,52432,09832,10232,090000240
       Other Assets 
0
86
1
-1
1
915
1
1
2,962
12,745
0
-1
-1012,7452,962119151-11860
> Total Liabilities 
4,444
4,031
4,500
3,880
5,635
19,393
33,136
66,625
81,591
71,470
131,052
164,644
164,644131,05271,47081,59166,62533,13619,3935,6353,8804,5004,0314,444
   > Total Current Liabilities 
2,121
1,892
4,044
3,547
5,343
8,493
12,393
24,944
31,521
28,036
70,042
92,834
92,83470,04228,03631,52124,94412,3938,4935,3433,5474,0441,8922,121
       Short-term Debt 
0
1
320
255
170
10,900
20,743
12
10,232
10,702
14,116
43,769
43,76914,11610,70210,2321220,74310,90017025532010
       Short Long Term Debt 
0
2,090
435
255
170
10,900
20,743
5,549
7
9,491
10,228
42,837
42,83710,2289,49175,54920,74310,9001702554352,0900
       Accounts payable 
1,562
1,050
2,808
2,571
4,219
6,654
10,545
17,408
18,558
15,475
47,221
43,824
43,82447,22115,47518,55817,40810,5456,6544,2192,5712,8081,0501,562
       Other Current Liabilities 
559
842
916
721
954
1
5
5,537
1,312
5,736
6,275
532
5326,2755,7361,3125,53751954721916842559
   > Long-term Liabilities 
2,323
2,139
456
333
292
10,900
20,743
41,681
50,070
43,434
61,010
71,810
71,81061,01043,43450,07041,68120,74310,9002923334562,1392,323
       Other Liabilities 
0
47
371
17
200
2
5
9
98
1,215
0
0
001,2159895220017371470
> Total Stockholder Equity
34,019
33,935
71,768
56,717
48,180
34,655
18,592
4,673
28,774
1,882
196,010
40,584
40,584196,0101,88228,7744,67318,59234,65548,18056,71771,76833,93534,019
   Common Stock
40
69
97
97
99
102
122
143
168
223
629
633
6336292231681431221029997976940
   Retained Earnings Total Equity000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
289
-37,260
282
283
112
-75
-75112283282-37,260289000000
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
38,956
92,716
91,973
94,656
96,951
111,213
28,563
110,419
150,476
478,218
478,905
478,905478,218150,476110,41928,563111,21396,95194,65691,97392,71638,9560



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-172,984
Operating Income-172,984-172,984
 
Operating Expense (+$)
Research Development146,532
Selling General Administrative38,900
Selling And Marketing Expenses-
Operating Expense172,984185,432
 
Net Interest Income (+$)
Interest Income8,956
Interest Expense-12,431
Other Finance Cost-1,089
Net Interest Income-4,564
 
Pretax Income (+$)
Operating Income-172,984
Net Interest Income-4,564
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-176,242-174,291
EBIT - interestExpense = -12,431
-176,242
-163,811
Interest Expense12,431
Earnings Before Interest and Taxes (EBIT)--163,811
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-176,242
Tax Provision-0
Net Income From Continuing Ops-176,242-176,242
Net Income-176,242
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net1,3074,564
 

Technical Analysis of Abivax
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Abivax. The general trend of Abivax is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Abivax's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Abivax Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ABIVAX Société Anonyme.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.89 < 5.89 < 5.89.

The bearish price targets are: .

Know someone who trades $AAVXF? Share this with them.👇

ABIVAX Société Anonyme Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ABIVAX Société Anonyme. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ABIVAX Société Anonyme Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ABIVAX Société Anonyme. The current macd is 0.01830947.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Abivax price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Abivax. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Abivax price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
ABIVAX Société Anonyme Daily Moving Average Convergence/Divergence (MACD) ChartABIVAX Société Anonyme Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ABIVAX Société Anonyme. The current adx is 57.37.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Abivax shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
ABIVAX Société Anonyme Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ABIVAX Société Anonyme. The current sar is 6.91.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ABIVAX Société Anonyme Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ABIVAX Société Anonyme. The current rsi is 14.71. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
ABIVAX Société Anonyme Daily Relative Strength Index (RSI) ChartABIVAX Société Anonyme Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ABIVAX Société Anonyme. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Abivax price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
ABIVAX Société Anonyme Daily Stochastic Oscillator ChartABIVAX Société Anonyme Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ABIVAX Société Anonyme. The current cci is -666.66666667.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
ABIVAX Société Anonyme Daily Commodity Channel Index (CCI) ChartABIVAX Société Anonyme Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ABIVAX Société Anonyme. The current cmo is -87.0675479.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ABIVAX Société Anonyme Daily Chande Momentum Oscillator (CMO) ChartABIVAX Société Anonyme Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ABIVAX Société Anonyme. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
ABIVAX Société Anonyme Daily Williams %R ChartABIVAX Société Anonyme Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ABIVAX Société Anonyme.

ABIVAX Société Anonyme Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ABIVAX Société Anonyme. The current atr is 0.10280496.

ABIVAX Société Anonyme Daily Average True Range (ATR) ChartABIVAX Société Anonyme Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ABIVAX Société Anonyme. The current obv is -6,100.

ABIVAX Société Anonyme Daily On-Balance Volume (OBV) ChartABIVAX Société Anonyme Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ABIVAX Société Anonyme. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
ABIVAX Société Anonyme Daily Money Flow Index (MFI) ChartABIVAX Société Anonyme Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ABIVAX Société Anonyme.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

ABIVAX Société Anonyme Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ABIVAX Société Anonyme based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5014.708
Ma 20Greater thanMa 506.855
Ma 50Greater thanMa 1006.339
Ma 100Greater thanMa 2007.885
OpenGreater thanClose5.810
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Abivax with someone you think should read this too:
  • Are you bullish or bearish on Abivax? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Abivax? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ABIVAX Société Anonyme

I send you an email if I find something interesting about ABIVAX Société Anonyme.


Comments

How you think about this?

Leave a comment

Stay informed about ABIVAX Société Anonyme.

Receive notifications about ABIVAX Société Anonyme in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.